Research ArticleOpen accessIn the keywordsQuantification of Zolpidem in Canine PlasmaMario Giorgi, Alessandra Gavazza, Hyoin YunProblem statement: Zolpidem is a non-benzodiazepine hypnotic agent currently used in human medicine. In contrast to benzodiazepines, zolpidem preferentially binds with the GABAA complex ϖ1 receptors while poorly interacting with the other ϖ receptor complexes. Recent studies have suggested that ZP may be used to initiate sedation and diminish severe anxiety responses in dogs. The aim of the present study … …American Journal of Animal and Veterinary Sciences, Vol. 7, Issue 1 · 19 Mar 2012 · 7,908 accessesView PDFCite
Research ArticleOpen accessIn the abstractMarketing Research Merely Reflects The Needs And Wants of ConsumersTheodossiou George, Kourti ChrisaIn the recent years, marketers have focused their attention on the consumer. The aim is the acquisition of comparative advantage in the market. They have succeeded to develop organizations oriented to the market, and departments that support the competition strategy for the satisfaction of the needs and the wants of the consumers. The golden rule of Marketing says that a … …American Journal of Applied Sciences, Vol. 4, Issue 8 · 31 Aug 2007 · 13,159 accessesView PDFCite
Research ArticleOpen accessIn the abstractA Modern Appraisal of Ancient Etruscan Herbal PracticesA. P. Harrison, E. M. BartelsIndividuals in antiquity would have been exposed to both cheese and red wine and perhaps as many as 10-40% of the population would have suffered at some time in their life from a migraine headache. Furthermore, individuals in antiquity would also have been exposed to their fair share of childhood stress and therefore would have been predisposed to arthritis in … …American Journal of Pharmacology and Toxicology, Vol. 1, Issue 2 · 30 Jun 2006 · 7,480 accessesView PDFCite
Research ArticleOpen accessIn the abstractEffects of a Topical Composition of GABA and Microbial Chondroitin Sulfate on Mental Calmness and Brain FunctionMarco RuggieroThis article describes a novel topical composition constituted by Gamma-Aminobutyric Acid (GABA) and microbial chondroitin sulfate. This composition, formulated by the author and manufactured in a certified facility in the United States of America, exhibits potential for non-invasive intervention in anxiety management, sleep quality enhancement and promotion of brain-related functions like meditation and nonlocal consciousness. The core component comprises GABA, … …American Journal of Immunology, Vol. 19, Issue 1 · 8 Mar 2024 · 11,673 accessesView PDFCite